GSA Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-130,595
| Closed | -$2.5M | – | 2149 |
|
|
2025
Q1 | $2.5M | Buy |
+130,595
| New | +$2.5M | 0.23% | 27 |
|
|
2024
Q3 | – | Sell |
-19,260
| Closed | -$776K | – | 2011 |
|
|
2024
Q2 | $776K | Buy |
19,260
+10,867
| +129% | +$438K | 0.05% | 685 |
|
|
2024
Q1 | $297K | Buy |
+8,393
| New | +$297K | 0.02% | 1223 |
|
|
2022
Q4 | – | Sell |
-10,138
| Closed | -$485K | – | 1890 |
|
|
2022
Q3 | $485K | Buy |
10,138
+4,877
| +93% | +$233K | 0.06% | 589 |
|
|
2022
Q2 | $311K | Buy |
5,261
+1,244
| +31% | +$73.5K | 0.05% | 800 |
|
|
2022
Q1 | $467K | Buy |
+4,017
| New | +$467K | 0.06% | 584 |
|
|
2021
Q3 | – | Sell |
-2,092
| Closed | -$204K | – | 1771 |
|
|
2021
Q2 | $204K | Buy |
+2,092
| New | +$204K | 0.02% | 1176 |
|
|
2020
Q4 | – | Sell |
-2,061
| Closed | -$234K | – | 1597 |
|
|
2020
Q3 | $234K | Buy |
+2,061
| New | +$234K | 0.04% | 909 |
|
|
2019
Q3 | – | Sell |
-9,368
| Closed | -$604K | – | 1708 |
|
|
2019
Q2 | $604K | Buy |
9,368
+513
| +6% | +$33.1K | 0.07% | 547 |
|
|
2019
Q1 | $562K | Buy |
+8,855
| New | +$562K | 0.06% | 626 |
|
|
2018
Q4 | – | Sell |
-15,118
| Closed | -$648K | – | 1735 |
|
|
2018
Q3 | $648K | Buy |
+15,118
| New | +$648K | 0.04% | 942 |
|